Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 29 entries
Sorted by: Best Match Show Resources per page
Career development for women in academic medicine: Multiple interventions in a department of medicine

ADVANCE: Organizational Change for Gender Equity in STEM Academic Professions AND Program Evaluation

Francomano CA.
GSID: ifE7NK9ssgwJ
LP Fried, CA Francomano, SM MacDonald… - Jama, 1996 - jamanetwork.com

Objective.—To determine the gender-based career obstacles for women in an academic department of medicine and to report the interventions to correct such obstacles (resulting from the evaluation) and the results of these interventions. Design.—Intervention study, before-after trial, with assessment...

Cite
Fried, L. P., Francomano, C. A., MacDonald, S. M., Wagner, E. M., Stokes, E. J., Carbone, K. M., ... & Stobo, J. D. (1996). Career development for women in academic medicine: Multiple interventions in a department of medicine. Jama, 276(11), 898-905.
Fried, Linda P., et al. "Career development for women in academic medicine: Multiple interventions in a department of medicine." Jama 276.11 (1996): 898-905.
Copy Download .nbib Format: MLA
Reconstruction of nasal skin cancer defects with local flaps.

Journal of skin cancer

Salgarelli AC, Bellini P, Multinu A, Magnoni C, Francomano M, Fantini F, Consolo U, Seidenari S.
PMID: 21773033
J Skin Cancer. 2011;2011:181093. doi: 10.1155/2011/181093. Epub 2011 Jun 07.

Reconstruction of nasal defects must preserve the integrity of complex facial functions and expressions, as well as facial symmetry and a pleasing aesthetic outcome. The reconstructive modality of choice will depend largely on the location, size, and depth of...

Cite
Salgarelli AC, Bellini P, Multinu A, et al. Reconstruction of nasal skin cancer defects with local flaps. J Skin Cancer. 2011;2011:181093doi: 10.1155/2011/181093.
Salgarelli, A. C., Bellini, P., Multinu, A., Magnoni, C., Francomano, M., Fantini, F., Consolo, U., & Seidenari, S. (2011). Reconstruction of nasal skin cancer defects with local flaps. Journal of skin cancer, 2011181093. https://doi.org/10.1155/2011/181093
Salgarelli, A C, et al. "Reconstruction of nasal skin cancer defects with local flaps." Journal of skin cancer vol. 2011 (2011): 181093. doi: https://doi.org/10.1155/2011/181093
Salgarelli AC, Bellini P, Multinu A, Magnoni C, Francomano M, Fantini F, Consolo U, Seidenari S. Reconstruction of nasal skin cancer defects with local flaps. J Skin Cancer. 2011;2011:181093. doi: 10.1155/2011/181093. Epub 2011 Jun 07. PMID: 21773033; PMCID: PMC3135072.
Copy Download .nbib Format: NLM
Negative association between trunk fat, insulin resistance and skeleton in obese women.

World journal of diabetes

Greco EA, Francomano D, Fornari R, Marocco C, Lubrano C, Papa V, Wannenes F, Di Luigi L, Donini LM, Lenzi A, Aversa A, Migliaccio S.
PMID: 23593534
World J Diabetes. 2013 Apr 15;4(2):31-9. doi: 10.4239/wjd.v4.i2.31.

AIM: To evaluate the potential interference of trunk fat (TF) mass on metabolic and skeletal metabolism.METHODS: In this cross-sectional study, 340 obese women (mean age: 44.8 ± 14 years; body mass index: 36.0 ± 5.9 kg/m(2)) were included. Patients...

Cite
Greco EA, Francomano D, Fornari R, et al. Negative association between trunk fat, insulin resistance and skeleton in obese women. World J Diabetes. 2013;4(2):31-9doi: 10.4239/wjd.v4.i2.31.
Greco, E. A., Francomano, D., Fornari, R., Marocco, C., Lubrano, C., Papa, V., Wannenes, F., Di Luigi, L., Donini, L. M., Lenzi, A., Aversa, A., & Migliaccio, S. (2013). Negative association between trunk fat, insulin resistance and skeleton in obese women. World journal of diabetes, 4(2), 31-9. https://doi.org/10.4239/wjd.v4.i2.31
Greco, Emanuela A, et al. "Negative association between trunk fat, insulin resistance and skeleton in obese women." World journal of diabetes vol. 4,2 (2013): 31-9. doi: https://doi.org/10.4239/wjd.v4.i2.31
Greco EA, Francomano D, Fornari R, Marocco C, Lubrano C, Papa V, Wannenes F, Di Luigi L, Donini LM, Lenzi A, Aversa A, Migliaccio S. Negative association between trunk fat, insulin resistance and skeleton in obese women. World J Diabetes. 2013 Apr 15;4(2):31-9. doi: 10.4239/wjd.v4.i2.31. PMID: 23593534; PMCID: PMC3627415.
Copy Download .nbib Format: NLM
A case-control study of respiratory medication and co-occurring gastrointestinal prescription burden among persons with Ehlers-Danlos syndromes.

American journal of medical genetics. Part C, Seminars in medical genetics

Bascom R, Dhingra R, Francomano CA, Schubart JR.
PMID: 34766427
Am J Med Genet C Semin Med Genet. 2021 Dec;187(4):549-560. doi: 10.1002/ajmg.c.31947. Epub 2021 Nov 12.

We previously reported increased pain and gastrointestinal (GI) medication prescription claims among persons with Ehlers-Danlos syndromes (EDS) and peripubertal increase in opioid and anti-emetic claims among women with EDS. Herein, we hypothesized a higher proportion of respiratory and co-occurring...

Cite
Bascom R, Dhingra R, Francomano CA, et al. A case-control study of respiratory medication and co-occurring gastrointestinal prescription burden among persons with Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2021;187(4):549-560doi: 10.1002/ajmg.c.31947.
Bascom, R., Dhingra, R., Francomano, C. A., & Schubart, J. R. (2021). A case-control study of respiratory medication and co-occurring gastrointestinal prescription burden among persons with Ehlers-Danlos syndromes. American journal of medical genetics. Part C, Seminars in medical genetics, 187(4), 549-560. https://doi.org/10.1002/ajmg.c.31947
Bascom, Rebecca, et al. "A case-control study of respiratory medication and co-occurring gastrointestinal prescription burden among persons with Ehlers-Danlos syndromes." American journal of medical genetics. Part C, Seminars in medical genetics vol. 187,4 (2021): 549-560. doi: https://doi.org/10.1002/ajmg.c.31947
Bascom R, Dhingra R, Francomano CA, Schubart JR. A case-control study of respiratory medication and co-occurring gastrointestinal prescription burden among persons with Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2021 Dec;187(4):549-560. doi: 10.1002/ajmg.c.31947. Epub 2021 Nov 12. PMID: 34766427.
Copy Download .nbib Format: NLM
Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine?.

Therapeutic advances in urology

Aversa A, Bruzziches R, Francomano D, Natali M, Lenzi A.
PMID: 21789066
Ther Adv Urol. 2009 Oct;1(4):179-97. doi: 10.1177/1756287209344992.

Normal vascular endothelium is essential for the synthesis and release of substances affecting vascular tone (e.g. nitric oxide; NO), cell adhesion (e.g. endothelins, interleukins), and the homeostasis of clotting and fibrinolysis (e.g. plasminogen inhibitors, von Willebrand factor). The degeneration...

Cite
Aversa A, Bruzziches R, Francomano D, et al. Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine?. Ther Adv Urol. 2009;1(4):179-97doi: 10.1177/1756287209344992.
Aversa, A., Bruzziches, R., Francomano, D., Natali, M., & Lenzi, A. (2009). Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine?. Therapeutic advances in urology, 1(4), 179-97. https://doi.org/10.1177/1756287209344992
Aversa, Antonio, et al. "Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine?." Therapeutic advances in urology vol. 1,4 (2009): 179-97. doi: https://doi.org/10.1177/1756287209344992
Aversa A, Bruzziches R, Francomano D, Natali M, Lenzi A. Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine?. Ther Adv Urol. 2009 Oct;1(4):179-97. doi: 10.1177/1756287209344992. PMID: 21789066; PMCID: PMC3126062.
Copy Download .nbib Format: NLM
Testosterone supplementation and bone parameters: a systematic review and meta-analysis study.

Journal of endocrinological investigation

Corona G, Vena W, Pizzocaro A, Giagulli VA, Francomano D, Rastrelli G, Mazziotti G, Aversa A, Isidori AM, Pivonello R, Vignozzi L, Mannucci E, Maggi M, Ferlin A.
PMID: 35041193
J Endocrinol Invest. 2022 Jan 18; doi: 10.1007/s40618-021-01702-5. Epub 2022 Jan 18.

BACKGROUND: The role of testosterone (T) replacement therapy (TRT) in subjects with late onset hypogonadism is still the object of an intense debate.METHODS: All observational studies and placebo-controlled or -uncontrolled randomized trials (RCTs) comparing the effect of TRT on...

Cite
Corona G, Vena W, Pizzocaro A, et al. Testosterone supplementation and bone parameters: a systematic review and meta-analysis study. J Endocrinol Invest. 2022;doi: 10.1007/s40618-021-01702-5.
Corona, G., Vena, W., Pizzocaro, A., Giagulli, V. A., Francomano, D., Rastrelli, G., Mazziotti, G., Aversa, A., Isidori, A. M., Pivonello, R., Vignozzi, L., Mannucci, E., Maggi, M., & Ferlin, A. (2022). Testosterone supplementation and bone parameters: a systematic review and meta-analysis study. Journal of endocrinological investigation, . https://doi.org/10.1007/s40618-021-01702-5
Corona, G, et al. "Testosterone supplementation and bone parameters: a systematic review and meta-analysis study." Journal of endocrinological investigation vol. (2022). doi: https://doi.org/10.1007/s40618-021-01702-5
Corona G, Vena W, Pizzocaro A, Giagulli VA, Francomano D, Rastrelli G, Mazziotti G, Aversa A, Isidori AM, Pivonello R, Vignozzi L, Mannucci E, Maggi M, Ferlin A. Testosterone supplementation and bone parameters: a systematic review and meta-analysis study. J Endocrinol Invest. 2022 Jan 18; doi: 10.1007/s40618-021-01702-5. Epub 2022 Jan 18. PMID: 35041193.
Copy Download .nbib Format: NLM
Patients with Ehlers-Danlos syndrome on the diagnostic odyssey: Rethinking complexity and difficulty as a hero's journey.

American journal of medical genetics. Part C, Seminars in medical genetics

Halverson CME, Clayton EW, Garcia Sierra A, Francomano C.
PMID: 34524722
Am J Med Genet C Semin Med Genet. 2021 Dec;187(4):416-424. doi: 10.1002/ajmg.c.31935. Epub 2021 Sep 15.

Patients with hypermobile Ehlers-Danlos syndrome, an hereditary disorder of the connective tissue, often face a long and difficult diagnostic odyssey in pursuit of a name for their condition. Clinicians may dismiss subjective symptoms of chronic pain, thus prolonging patients'...

Cite
Halverson CME, Clayton EW, Garcia Sierra A, et al. Patients with Ehlers-Danlos syndrome on the diagnostic odyssey: Rethinking complexity and difficulty as a hero's journey. Am J Med Genet C Semin Med Genet. 2021;187(4):416-424doi: 10.1002/ajmg.c.31935.
Halverson, C. M. E., Clayton, E. W., Garcia Sierra, A., & Francomano, C. (2021). Patients with Ehlers-Danlos syndrome on the diagnostic odyssey: Rethinking complexity and difficulty as a hero's journey. American journal of medical genetics. Part C, Seminars in medical genetics, 187(4), 416-424. https://doi.org/10.1002/ajmg.c.31935
Halverson, Colin Michael Egenberger, et al. "Patients with Ehlers-Danlos syndrome on the diagnostic odyssey: Rethinking complexity and difficulty as a hero's journey." American journal of medical genetics. Part C, Seminars in medical genetics vol. 187,4 (2021): 416-424. doi: https://doi.org/10.1002/ajmg.c.31935
Halverson CME, Clayton EW, Garcia Sierra A, Francomano C. Patients with Ehlers-Danlos syndrome on the diagnostic odyssey: Rethinking complexity and difficulty as a hero's journey. Am J Med Genet C Semin Med Genet. 2021 Dec;187(4):416-424. doi: 10.1002/ajmg.c.31935. Epub 2021 Sep 15. PMID: 34524722.
Copy Download .nbib Format: NLM
Longitudinal analysis of symptoms in the Ehlers-Danlos syndromes.

American journal of medical genetics. Part A

Schubart JR, Mills SE, Schaefer EW, Bascom R, Francomano CA.
PMID: 34994522
Am J Med Genet A. 2022 Jan 07; doi: 10.1002/ajmg.a.62640. Epub 2022 Jan 07.

Our study extends a cross-sectional dataset on the Ehlers-Danlos syndromes (EDS) assembled by the National Institute on Aging (NIA), under a protocol entitled Clinical and Molecular Manifestations of Heritable Disorders of Connective Tissue. We were successful in contacting 171...

Cite
Schubart JR, Mills SE, Schaefer EW, et al. Longitudinal analysis of symptoms in the Ehlers-Danlos syndromes. Am J Med Genet A. 2022;doi: 10.1002/ajmg.a.62640.
Schubart, J. R., Mills, S. E., Schaefer, E. W., Bascom, R., & Francomano, C. A. (2022). Longitudinal analysis of symptoms in the Ehlers-Danlos syndromes. American journal of medical genetics. Part A, . https://doi.org/10.1002/ajmg.a.62640
Schubart, Jane R, et al. "Longitudinal analysis of symptoms in the Ehlers-Danlos syndromes." American journal of medical genetics. Part A vol. (2022). doi: https://doi.org/10.1002/ajmg.a.62640
Schubart JR, Mills SE, Schaefer EW, Bascom R, Francomano CA. Longitudinal analysis of symptoms in the Ehlers-Danlos syndromes. Am J Med Genet A. 2022 Jan 07; doi: 10.1002/ajmg.a.62640. Epub 2022 Jan 07. PMID: 34994522.
Copy Download .nbib Format: NLM
Ehlers-Danlos syndromes, hypermobility spectrum disorders, and associated co-morbidities: Reports from EDS ECHO.

American journal of medical genetics. Part C, Seminars in medical genetics

Hakim AJ, Tinkle BT, Francomano CA.
PMID: 34793630
Am J Med Genet C Semin Med Genet. 2021 Dec;187(4):413-415. doi: 10.1002/ajmg.c.31954. Epub 2021 Nov 18.

No abstract available.

Cite
Hakim AJ, Tinkle BT, Francomano CA. Ehlers-Danlos syndromes, hypermobility spectrum disorders, and associated co-morbidities: Reports from EDS ECHO. Am J Med Genet C Semin Med Genet. 2021;187(4):413-415doi: 10.1002/ajmg.c.31954.
Hakim, A. J., Tinkle, B. T., & Francomano, C. A. (2021). Ehlers-Danlos syndromes, hypermobility spectrum disorders, and associated co-morbidities: Reports from EDS ECHO. American journal of medical genetics. Part C, Seminars in medical genetics, 187(4), 413-415. https://doi.org/10.1002/ajmg.c.31954
Hakim, Alan J, et al. "Ehlers-Danlos syndromes, hypermobility spectrum disorders, and associated co-morbidities: Reports from EDS ECHO." American journal of medical genetics. Part C, Seminars in medical genetics vol. 187,4 (2021): 413-415. doi: https://doi.org/10.1002/ajmg.c.31954
Hakim AJ, Tinkle BT, Francomano CA. Ehlers-Danlos syndromes, hypermobility spectrum disorders, and associated co-morbidities: Reports from EDS ECHO. Am J Med Genet C Semin Med Genet. 2021 Dec;187(4):413-415. doi: 10.1002/ajmg.c.31954. Epub 2021 Nov 18. PMID: 34793630.
Copy Download .nbib Format: NLM
Penile involvement in Systemic Sclerosis: New Diagnostic and Therapeutic Aspects.

International journal of rheumatology

Aversa A, Bruzziches R, Francomano D, Rosato E, Salsano F, Spera G.
PMID: 20981315
Int J Rheumatol. 2010;2010:708067. doi: 10.1155/2010/708067. Epub 2010 Oct 05.

Systemic Sclerosis (SSc) is a connective tissue disorder featuring vascular alterations and an immunological activation leading to a progressive and widespread fibrosis of several organs such as the skin, lung, gastrointestinal tract, heart, and kidney. Men with SSc are...

Cite
Aversa A, Bruzziches R, Francomano D, et al. Penile involvement in Systemic Sclerosis: New Diagnostic and Therapeutic Aspects. Int J Rheumatol. 2010;2010:708067doi: 10.1155/2010/708067.
Aversa, A., Bruzziches, R., Francomano, D., Rosato, E., Salsano, F., & Spera, G. (2010). Penile involvement in Systemic Sclerosis: New Diagnostic and Therapeutic Aspects. International journal of rheumatology, 2010708067. https://doi.org/10.1155/2010/708067
Aversa, Antonio, et al. "Penile involvement in Systemic Sclerosis: New Diagnostic and Therapeutic Aspects." International journal of rheumatology vol. 2010 (2010): 708067. doi: https://doi.org/10.1155/2010/708067
Aversa A, Bruzziches R, Francomano D, Rosato E, Salsano F, Spera G. Penile involvement in Systemic Sclerosis: New Diagnostic and Therapeutic Aspects. Int J Rheumatol. 2010;2010:708067. doi: 10.1155/2010/708067. Epub 2010 Oct 05. PMID: 20981315; PMCID: PMC2958513.
Copy Download .nbib Format: NLM
Effects of five-year treatment with testosterone undecanoate on metabolic and hormonal parameters in ageing men with metabolic syndrome.

International journal of endocrinology

Francomano D, Lenzi A, Aversa A.
PMID: 24688542
Int J Endocrinol. 2014;2014:527470. doi: 10.1155/2014/527470. Epub 2014 Feb 12.

Metabolic and hormonal modifications after long-term testosterone (T) treatment have never been investigated. 20 hypogonadal men (mean T = 241 ng/dL-8.3 nmol/L) with metabolic syndrome (MS, mean age 58) were treated with T-undecanoate injections every 12 weeks for 60...

Cite
Francomano D, Lenzi A, Aversa A. Effects of five-year treatment with testosterone undecanoate on metabolic and hormonal parameters in ageing men with metabolic syndrome. Int J Endocrinol. 2014;2014:527470doi: 10.1155/2014/527470.
Francomano, D., Lenzi, A., & Aversa, A. (2014). Effects of five-year treatment with testosterone undecanoate on metabolic and hormonal parameters in ageing men with metabolic syndrome. International journal of endocrinology, 2014527470. https://doi.org/10.1155/2014/527470
Francomano, Davide, et al. "Effects of five-year treatment with testosterone undecanoate on metabolic and hormonal parameters in ageing men with metabolic syndrome." International journal of endocrinology vol. 2014 (2014): 527470. doi: https://doi.org/10.1155/2014/527470
Francomano D, Lenzi A, Aversa A. Effects of five-year treatment with testosterone undecanoate on metabolic and hormonal parameters in ageing men with metabolic syndrome. Int J Endocrinol. 2014;2014:527470. doi: 10.1155/2014/527470. Epub 2014 Feb 12. PMID: 24688542; PMCID: PMC3945028.
Copy Download .nbib Format: NLM
Cardiometabolic complications after androgen deprivation therapy in a man with prostate cancer: effects of 3 years intermittent testosterone supplementation.

Frontiers in endocrinology

Aversa A, Francomano D, Lenzi A.
PMID: 22645517
Front Endocrinol (Lausanne). 2012 Feb 16;3:17. doi: 10.3389/fendo.2012.00017. eCollection 2012.

Androgen deprivation therapy (ADT) for prostate carcinoma (PCa) may cause cardiometabolic complications unless intermittent androgen blockade (IAB) is instituted. An 80-year-old caucasian man was diagnosed intermediate grade (Gleason 4 + 3) PCa and was treated with continuous ADT with...

Cite
Aversa A, Francomano D, Lenzi A. Cardiometabolic complications after androgen deprivation therapy in a man with prostate cancer: effects of 3 years intermittent testosterone supplementation. Front Endocrinol (Lausanne). 2012;3:17doi: 10.3389/fendo.2012.00017.
Aversa, A., Francomano, D., & Lenzi, A. (2012). Cardiometabolic complications after androgen deprivation therapy in a man with prostate cancer: effects of 3 years intermittent testosterone supplementation. Frontiers in endocrinology, 317. https://doi.org/10.3389/fendo.2012.00017
Aversa, Antonio, et al. "Cardiometabolic complications after androgen deprivation therapy in a man with prostate cancer: effects of 3 years intermittent testosterone supplementation." Frontiers in endocrinology vol. 3 (2012): 17. doi: https://doi.org/10.3389/fendo.2012.00017
Aversa A, Francomano D, Lenzi A. Cardiometabolic complications after androgen deprivation therapy in a man with prostate cancer: effects of 3 years intermittent testosterone supplementation. Front Endocrinol (Lausanne). 2012 Feb 16;3:17. doi: 10.3389/fendo.2012.00017. eCollection 2012. PMID: 22645517; PMCID: PMC3355839.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 29 entries